CD8A and type 1 diabetes mellitus: Foxp3-expressing CD8+ Tregs have been reported to be important suppressive players in autoimmune disease such as type 1 diabetes and especially in the context of transplantation where donor cells continue to express MHCI for long time periods following the graft (41).